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Osthole is an active coumarin extracted from Cnidium monnieri (L.) Cusson, a traditional Chinese herb which possesses 
multiple pharmacological activities. Asthma is a long term disease characterized by chronic airway inflammation and hyper-
responsiveness. Worldwide, around 339 million people are reported to be suffering from asthma. Coumarin osthole has been 
known to exhibitanti-inflammatory and antiallergic activities. Here, we investigated mechanisms underlying the protective 
effects of osthole in ovalbumin (OVA) induced asthmatic mice. A total 40 C57BL/6 male mice were used as experimental 
model animals. The results showed that osthole treatment significantly reduces OVA-induced elevated levels of serum IgE 
and inflammatory cytokines (IL-4, IL-5, IL-6, IL-13) except IL-10 in bronchoalveolar lavage fluid (BALF), and decreased the 
recruitment of inflammatory cells in BALF. The CCK-8 assay was performed to examine the viability of cells. The enzyme 
linked immunosorbent assay (ELISA) was used to determine the expression of inflammatory factors. Western blot analysis 
was conducted to examine TLR9 and JNK protein expression. Results showed that osthole significantly inhibits the 
recruitment of inflammatory cells and Th1/Th2 cytokines expression in BALF and airway hyper-responsiveness. Furthermore, 
osthole attenuated upregulation of systemic immunoglobulin production derived from OVA sensitization. Results also suggest 
that osthole can reverse the imbalance of Thlfrh2 in asthma, thus alleviating the symptoms of asthma to a certain extent. In 
conclusion, the study demonstrated that osthole, activecoumarin extract of Cnidium monnieri, attenuated the allergic airway 
inflammation via inhibition of TLR9/JNK pathway in mice model indicating that it could be a potential therapeutic target for 
asthma.  
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Asthma is a chronic heterogeneous inflammatory 
disease caused by genetic and environmental factors, 
characterized by varying degrees of airway spasm and 
hyper-responsiveness, mucus secretion and chronic 
inflammation1. Among them, chronic airway 
inflammation is an important direct cause of repeated 
exacerbation and airway remodeling2. According to the 
World Health Organization (WHO) report 2018, asthma 
is estimated to affect 339 million people of all ages 
worldwide. Globally, asthma is ranked 16th among the 
leading causes of years lived with disability and 28th 
among the leading causes of burden of disease, as 
measured by disability adjusted life years3. 
At present, the treatment of asthma by traditional 
Chinese medicine is generally divided into acute attack 
stage and chronic remission stage4. In traditional 
Chinese medicine, decoction of Cnidium Monnieri 
(commonly called Monnier's snowparsley, and locally 
She Chuang Zi), thecoumarin osthole being its main 
component, can effectively treat and control the acute 
attack of asthma, improve the lung function of patients, 
reduce airway resistance, and regulate the immune 
dysfunction of the body5. The mechanism of action of 
traditional Chinese medicine (osthole) needs to be 
understood for developing effective drugs to control 
airway inflammation, to improve the quality of life and 
prognosis of patients with bronchial asthma, and to 
reduce the proportion of patients with severe asthma 
and refractory asthma6. 
—————— 
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Osthole exhibits anti-asthmatic activity and 
prevents airway inflammation by producing Th2 
cytokines, IgE, recruitment of eosinophils and mucus 
overproduction6. Studies indicate that osthole has 
noticeable protective effect on histamine and 
acetylcholine-induced drug-induced asthma, and 
directly expands isolated bronchial smooth muscle7. 
Although the mortality rate of severe asthma has 
declined with regular use of corticosteroids (ICS) 
based inhalers. However, the impact of asthma is still 
enormous and its incidence has gradually increased in 
recent years8.  
Heterogeneous chronic inflammatory asthma has 
multiple phenotypes. Allergic asthma is a type of  
T helper 2 (Th2)-associated asthma and responses to it 
are characterized by the involvement of allergen-
specific immunoglobulin E (IgE) and Th2 cells9. The 
balance of T helper cell Th1/Th2 is closely related to 
the prognosis of asthma10. Reports suggest that 
Th1/Th2 imbalance is the immunological mechanism 
of bronchial asthma11. During the course of asthma, the 
synthesis of cytokines, such as interleukin 4  
(IL-4), IL-5, IL-6 and IL-13 in Th2 cells increase, the 
expression of cytokines (such as IL-12, IFN-gamma) 
in Th1 cells decreases, and specific IgE increases 
resulting in airway inflammation, eosinophil 
proliferation, and immune activation jointly leading to 
the development of chronic airway inflammation12,13. 
Moreover, chronic inflammation induces mast cells, 
eosinophils and neutrophils which in turn lead to 
airway epithelial injury, smooth muscle hypertrophy, 
goblet cell metaplasia and mucous gland hyperplasia, 
all of which are important characteristics of bronchial 
asthma14.  
Sanchez-Zauco et al.15 have reported that 
significant decrease of Toll-Like Receptor 9 (TLR9) 
expression may imbalance Th1/Th2 ratio, thereby 
could be used effectively for treating asthma. TLR9 
plays an important role in the inflammatory and 
immune response, cell signal transduction in asthma, 
and is closely related to airway inflammation and 
airway remodeling in asthma16. TLR-9 signaling has 
been implicated as a critical component of the 
inflammatory response following lung injury by 
Suresh et al.17. In addition, it has been reported that 
JNK signaling pathway not only increases the number 
of eosinophils and lymphocytes, but, also promotes 
airway remodeling by stimulating inflammatory 
mediators in airway smooth muscle cells and altering 
inflammation of airway sub-mucosal airway cells18,19. 
The active ingredients of C. monnieri mainly contain 
compounds which are called total coumarins20. There 
are six monomers isolated from C. monnieri7. Among 
them, osthole content is the highest accounting for 
about 60% of the total coumarin21. Previous studies 
have confirmed that osthole has significant effects on 
vasodilation, sedation, analgesia, antagonism, 
anticancer and allergic reaction22. Whether osthole has 
anti-asthmatic and anti-inflammatory effects and its 
underlying mechanisms are not yet fully understood. 
In this study, we investigated the effects of osthole 
on expression of Th1/Th2-related inflammatory factors 
in OVA-induced bronchial asthma in mice. In addition, 
we also studied the effect of osthole on airway 
resistance of asthma, and further explored its possible 
mechanism to provide theoretical basis for the 
treatment of asthma by osthole.  
 
Materials and Methods 
 
Animals 
Total 40 C57BL/6 male mice procured from 
Shanghai Slac Laboratory Animal Co. Ltd (Shanghai, 
China) were used in the study. Mice were housed for 
3 days to adapt themselves to the environment and 
then divided into four groups: Control group, OVA 
group (25 μg/mouse), OVA + Osthole (5 mg/kg) 
group and dexamethasone group (DEX, 1.5 mg/kg). 
The study was approved by the Animal Experiments 
Committee of Yancheng TCM Hospital affiliated to 
Nanjing University of Chinese Medicine, Nanjing, 
China. Osthole, dexamethasone and ovalbumin 
(grade V) were purchased from Sigma (St. Louis, 
MO, USA). All other chemicals were of reagent 
grade. 
 
Cell culture and treatment 
The bronchial epithelial cell line (BEAS-2B cells) 
was incubated with serial concentrations of osthole  
(2-80 mg/kg) for 24 h. Then, the treated cells were 
tested for the cell viability. 
 
Cell counting Kit-8 (CCK-8) assay 
Volume of 100uL cell suspension was added to 96-
well plate for 24 h with 5% CO2 at 37°C. The osthole 
was then administered at different concentrations for 
24 h. Then, 10uL of CCK-8 solution was added to each 
well and incubated in incubator for 2 h. Absorbance 
was taken at 450 nm by enzyme marker.  
 
ELISA assay  
Bronchoalveolar Lavage Fluid (BALF) was 
collected from different mice groups. After collection, 
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the supernatant in each group was harvested at 48 h and 
stored at −80°C until it was used for cytokine 
measurements. The total serum IgE, IgG1 and IgG2a 
levels were measured by ELISA kits (Bioscience, CA, 
USA) in line with the manufacturer’s instructions23. 
 
Cell flow cytometry 
The cells purified from lungs of four mice groups 
were resuspended in staining buffer and was analyzed 
by cell flow cytometry to determine the number and 
proportion of different inflammatory cells. Flow 
cytometry acquisition was performed using a FACS-
Calibur (BD Bioscience, CA, USA), and the results 
were analyzed using CellQuest software (BD 
Bioscience, CA, USA).  
 
Western blot analysis 
The proteins of different mice groups were 
extracted and detected, then boiled for 10 minutes. The 
proteins were separated by electrophoresis and 
transmembraned, and then incubated overnight with 
primary antibody of TLR9 (Abcam, CA, USA) and P-
JNK (Abcam, CA, USA) at 4°C. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) is used as internal 
reference (Abcam, CA, USA). Then, nitrocellulose 
membranes were incubated with second antibody for 
2h and washed with TBST thrice, 20 min each time. 
The bands were detected by chemi-luminescence 
method (Thermo Scientific, USA). 
 
Statistical analysis 
Statistical software platform SPSS 17.0 (SPSS, 
USA) was used for statistical analysis. The data were 
analyzed as mean ± SEM. Statistical differences were 
determined by Student’s t-test and one-way ANOVA. 
The P<0.05 was considered statistically significant. 
 
Results and Discussion 
 
Selection of suitable concentration of osthole 
Osthole (7-methoxy-8 [3-methylpent 2-enyl] 
coumarin) is an active coumarin extracted from the 
dried fruits of the king of traditional Chinese medicine, 
the C. monnieri. The chemical structure of osthole is 
shown in Fig. 1A. To investigate the optimum 
concentration of osthole for activity, BEAS-2B cell 
were incubated with serial concentrations of osthole  
(2-80 mg/kg), and the result demonstrated that there 
was no visible toxicity until the concentration of 
osthole exceeded 50 mg/kg (Fig. 1B). Hence, 50 mg/kg 
osthole was selected as final concentration for further 
research. Another study also used three different 
concentrations of osthole (25, 50 and 100 mg/kg) for 
evaluating its effect on influx of inflammatory cells in 
BALF of OVA-induced asthma murine models24. 
 
Osthole inhibited recruitment of inflammatory cells in BALF 
and airway hyper-responsiveness 
To assess the inhibitory activity of osthole on 
inflammation and airway hyper-responsiveness 
induced by OVA, the numbers of total inflammatory 
cells, macrophage, eosinophil, neutrophil and 
lymphocyte collected from bronchoalveolar lavage 
fluid (BALF) in OVA-induced asthma murine models 
given different treatments were monitored. There was 
a significant difference between control and OVA-
challenged group in total inflammatory cells, 
macrophage, eosinophil, neutrophil and lymphocyte 
(Fig. 2A). Moreover, OVA-induced increase of total 
inflammatory cells, macrophage, eosinophil, 
neutrophil and lymphocyte were all dramatically 
reduced by osthole at a concentration of 5 mg/kg body 
wt. or DEX (1.5 mg/kg) treatment. In this study, such 
OVA-triggered elevation was evidently attenuated by 
oral administration of osthole. In a similar study, it was 
found that treatment of osthole (25, 50 and 100 mg/kg) 
and DEX (2 mg/kg) markedly prevented the increase 
in inflammatory cells in BALF in a dose-dependent 
manner24. Another study also showed that oral 
treatment of mice with osthole at medium (25 mg/mL) 
and high doses (50 mg/mL) markedly reduced the 
infiltration of these inflammatory cells, particularly 
eosinophils9. 
The airway hyper-responsiveness represented by 
airway resistance (RL) was analyzed in OVA-induced 
asthmatic mice under osthole or DEX treatment to 
evaluate its triggered anti-allergic effects on asthma. 
Results indicated that after one exposure to a series of 
 
 
 
Fig. 1 — Selection of suitable concentration of osthole (A) The 
chemical structure of osthole; and (B) CCK-8 was used to detect 
the cell viability of BEAS-2B cell treated with various 
concentrations of osthole (2-80 mg/kg) for 24 h. [Each experiment 
were conducted in triplicates] 
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osthole concentration gradients (1-15 mg/mL), the 
relative RL was evidently enhanced in OVA-induced 
group (Fig. 2B).  
Asthma is an inflammatory disease regulated by 
a variety of cytokines, with eosinophils, 
lymphocytes and mast cells infiltrating mainly, and 
many kinds of cells participating in it25. Asthma is 
characterized by infiltration of inflammatory cells in 
the airway, exfoliation of airway epithelium and 
airway hyper-responsiveness26. The early 
pathological changes of asthma are mainly small 
airway inflammation. With the progression of 
asthma, long-term airway inflammation can  
lead to airway remodeling27. With the deepening 
understanding of asthma, the focus of treatment has 
shifted from simply relieving symptoms of airway 
smooth muscle spasm to comprehensive treatment 
based on asthma education and prevention and 
treatment of airway inflammation28. 
 
Osthole suppress Th1/Th2 cytokines expression in BALF of 
OVA-induced asthma murine model 
Imbalanced expression of Th1/Th2-related 
inflammatory factors, airway hyper responsiveness 
and changes in the number of airway inflammatory 
cells are consistent indicators of asthma attack and 
severity10, and the imbalance in Th1/Th2 cells are 
involved in the pathogenesis of asthma29. Hence, to 
verify the therapeutic efficacy of osthole as a new 
strategy in the treatment of asthma, the relevant 
Th1/Th2 cytokines in the BALF of mice treated by 
varied strategies were analyzed by ELISA. 
Consequently, the results demonstrated that the 
levels of interleukin IL-4 (Fig. 3A), IL-5 (Fig. 3B), 
IL-6 (Fig. 3C), IL-10 (Fig. 3D), IL-13 (Fig. 3E) and 
eosinophil-specific chemokines eotaxin (Fig. 3F) 
were all distinctly increased via OVA-challenged 
mice as compared to the control group, while such 
upregulation was effectively attenuated by osthole or 
DEX treatment except for IL-10. As illustrated in 
Fig. 3D, the level of IL-10 in the BALF was 
 
 
 
Fig. 3 — Osthole inhibits Th1/Th2 cytokines expression in BALF of OVA-induced asthma murine model: The levels of Th1/Th2 
cytokines, including  (A-E) IL-4, IL-5, IL-6, IL-10 and IL-13, respectively and eotaxin were all measured in the BALF of mice under 
described treatments by ELISA. [Each experiment was conducted three times independently, *P<0.05, **P<0.01] 
 
 
 
 
Fig. 2 — Effects of osthole on inflammation and airway hyper-
responsiveness. (A) Number of total inflammatory cells, 
macrophage, eosinophil, neutrophil and lymphocyte collected from 
BALF in mice given different treatments; and (B) The airway 
resistance (RL) of mice under different treatments upon exposure to 
stimulation of serial concentrations of osthole (1-15 mg/mL). [Each 
experiment was conducted in triplicates, *P<0.05, **P<0.01] 
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enhanced to a significant extent upon exposure to 
osthole or DEX treatment. Taken together, all these 
results indicated that osthole exert significant 
inhibition on Th1/Th2 cytokines expression in 
BALF of OVA-induced asthma murine model, 
thereby conferring its potential as new strategy to 
treat asthma. Similarly, administration of osthole 
and DEX dose-dependently suppressed the cytokine 
(IL-4, IL-5, and IL-13) elevation compared to the 
OVA-challenged group24. Chiang et al.9 showed that 
oral administration of osthole to BALB/c mice 
sensitization with OVA suppressed the production of 
Th2-type cytokines including IL-4, IL-5 and IL-13. 
On contrary, IL-10 production was not inhibited and 
was even enhanced by osthole treatment.  
 
In this study, it was found that osthole significantly 
inhibited recruitment of inflammatory cells and 
Th1/Th2 cytokines expression (IL-4, IL-5, IL-6, IL-13) 
in BALF and airway hyper-responsiveness. Data 
suggest that osthole can reverse the imbalance of 
Thl/Th2 in asthma, thus alleviating the symptoms of 
asthma to a certain extent.  
 
Osthole attenuates upregulation of systemic immunoglobulin 
production derived from OVA sensitization 
The high expression of systemic immunoglobulins, 
especially IgE and IgG1, is recognized as a primary 
feature of OVA-induced asthma. Therefore, to further 
validate the function of osthole in asthmatic 
inflammatory responses, the OVA-specific IgE and 
IgG1 levels in serum were analyzed. Another study 
also found that osthole and DEX treatment suppressed 
the levels of OVA-specific IgE in a dose dependent 
manner24. Results depicted that there was a measurable 
downward tendency of OVA-specific IgE and  
IgG1 levels upon exposure to osthole or DEX 
administration, which implied that osthole 
performance in improving OVA-induced asthmatic 
inflammation (Fig. 4). Furthermore, osthole attenuates 
up-regulation of systemic immunoglobulin production 
derived from OVA sensitization.  
 
Osthole inhibits allergic airway injury through TLR9/JNK 
pathway 
Although results of the present study demonstrated 
the therapeutic efficacy of osthole in asthma, however, 
the underlying mechanism is still not clear. It is also 
known that the Toll-like receptor 9 (TLR9) plays a 
pivotal role in the treatment of asthma due to its 
regulation of imbalance of Th1/Th2. Therefore, to 
validate the function of TLR9 pathway in the activity 
of osthole, the protein levels of TLR9 and p-Jun N-
terminal kinase (JNK) were detected by western blot 
assays. Compared with control group, both TLR9 and 
p-JNK expression were upregulated via OVA 
sensitization (Fig. 5). Results indicated that the protein 
levels of TLR9 and p-JNK were significantly reduced 
by osthole or DEX administration. Thus, osthole can 
regulate TLR9/JNK pathway, preliminarily revealing 
 
 
 
Fig. 4 — Osthole inhibits increased systemic immunoglobulin 
production caused by OVA sensitization. (A) The serum levels of 
OVA-specific IgE (A) and IgG1; and (B) in OVA-induced 
asthmatic murine model under described therapeutic treatments 
were detected by ELISA. [All the data are presented as mean 
value± SD. Each experiment was conducted three times 
independently, *P<0.05, **P<0.01] 
 
 
 
 
 
Fig. 5— Osthole in inhibits allergic airway inflammation via regulating TLR9/JNK pathway.(A) The protein levels of TLR9 and p-JNK in 
airway epithelial cells of mice under various approaches; and Quantification of grey levels of (B) TLR9; and (C) p-JNK in airway epithelial 
cells treated as depicted. [All the data are presented as mean value± SD. Each experiment was conducted three times independently, 
**P<0.01] 
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the therapeutic potential of Cnidium monnieri in 
treating the asthma. 
 
Conclusion  
Results of this study have confirm that osthole, the 
coumarin extract of the traditional Chinese herb 
Cnidium monnieri, locally called She chuang zi, 
alleviated airway resistance, regulate the expression of 
Th1/Th2-related inflammatory factors and reversed the 
imbalance of Th1/Th2 in asthmatic mice. 
Simultaneously, osthole reduced the content of 
eosinophils and macrophages, improved the 
inflammatory infiltration in lung tissue, thereby 
alleviating the asthmatic symptoms. Inhibition of 
TLR9/JNK pathway by osthole as observed here thus 
supports possible use of osthole as a therapeutic drug 
for patients with allergic asthma. 
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